Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.
Captor Therapeutics has raised $17.7M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Captor Therapeutics's investors include EIC Accelerator.
Captor Therapeutics is headquartered in Wroclaw, Poland.
Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.
Captor Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Captor Therapeutics — Funding & Investors." VCBacked, March 27, 2026, https://www.vcbacked.co/company/captor-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). Captor Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/captor-therapeutics
{{cite web |title=Captor Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/captor-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated